The role of endothelial cells in inflammation

Transplantation

Volumn 50, Issue 4, 1990, Pages 537-544

  Pober, Jordan S ^a   Cotran, Ramzi S ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE;

ENDOTHELIUM CELL; HUMAN; INFLAMMATION; LEUKOCYTE ADHERENCE; PRIORITY JOURNAL; REVIEW; VASODILATATION;

ANIMAL; CELL ADHESION; CELL ADHESION MOLECULES; CYTOKINES; ENDOTHELIUM, VASCULAR; HEMODYNAMICS; HUMAN; INFLAMMATION; LEUKOCYTES;

EID: 0025165359     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199010000-00001     Document Type: Article

References (69)

1. Cohnheim J. Lectures in general pathology (translated by McKee AD from the second German edition, vol. 1). London: New Sydenham Society, 1889.
2. Rampart M, Williams TJ. Polymorphonuclear leukocyte-depend- ent plasma leakage in rabbit skin is enhanced or inhibited by prostacyclin, depending on the route of administration. Am J Pathol 1986; 124: 66.
3. Brenner BM, Troy JL, Baltermann BJ. Endothelium-dependent vascular responses: mediators and mechanisms. J Clin Invest 1989; 84:1373.
4. Jaffe EA, Grulich J, Weksler BB, Hampel G, Watanabe K. Correlation between thrombin-induced prostacyclin production and inositol trisphosphate and cytosolic free calcium levels in cultured human endothelial cells. J Biol Chem 1987; 262: 8557.
5. Zavoico GB, Ewenstein BM, Schafer AI, Pober JS. Interleukin-1 and related cytokines enhance thrombin-stimulated PGL production in cultured endothelial cells without affecting thrombin- stimulated von Willebrand factor secretion or platelet activator factor biosynthesis. J Immunol 1989; 142: 3993.
6. Frasier-Scott K, Hatzakis H, Seong D, Jones CM, Wu KK. Influence of natural and recombinant interleukin 2 on endothelial cell arachidonate metabolism: induction of de novo synthesis of prostaglandin H synthetase. J Clin Invest 1988; 82:1877.
7. Pober JS. Cytokine-mediated activation of vascular endothelium: physiology and pathology. Am J Pathol 1988; 133: 426.
8. Wilms-Kretschmer K, Flax MH, Cotran RS. The fine structure of the vascular response in hapten-specific delayed hypersensitivity and contact dermatitis. Lab Invest 1967; 17: 334.
9. Bredt DS, Snyder SH. Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc Natl Acad Sci USA 1990; 87: 682.
10. Harlan JM, Thompson PJ, Ross RR, Bowen-Pope DF. a-Thrombin induces release of platelet-derived growth factor-like molecule(s) by cultured human endothelial cells. J Cell Biol 1986; 103:1129.
11. Hajjar KA, Hajjar DP, Silverstein RL, Nachman RL. Tumor necrosis factor-mediated release of platelet-derived growth factor from cultured endothelial cells. J Exp Med 1987; 166: 235.
12. Whatley RE, Zimmerman GA, McIntyre TM, Prescott SM. Endothelium from diverse vascular sources synthesizes platelet- activating factor. Arteriosclerosis 1988; 8: 321.
13. Halonen M, Palmer JD, Lohman IC, McManus LM, Pinchard RN. Respiratory and circulatory alterations induced by acetyl glyceryl ether phosphorylcholine, a mediator of IgE anaphylaxis in the rabbit. Am Rev Resp Dis 1980; 122: 915.
14. Rees DD, Palmer RMJ, Moncada S. Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc Natl Acad Sci USA 1989; 86: 3375.
15. Larsen CG, Anderson AO, Appella E, Oppenheim J J, MatsushimaK. Neutrophil activating protein (NAP-1) is also chemotactic for T lymphocytes. Science 1989; 243:1464.
16. Colditz I, Zwahlen R, Dewald B, Baggiolini M. In viyo inflammatory activity of neutrophil activating factor, a novel chemotactic peptide derived from human monocytes. Am J Pathol 1989; 134: 755.
17. Majno G, Shea SM, Leventhal M. Endothelial contraction induced by histamine-type mediators: an electron microscopic study. J Cell Biol 1969; 42: 647.
18. Wysolmerski RB, Lagunoff D. Involvement of myosin light chain kinase in endothelial cell retraction. Proc Natl Acad Sci USA 1990; 87:16.
19. Dahlen S, Bjork J, Hedqvist P, et al. Leukotrienes promote plasma leakage and leukocyte adhesion in post-capillary venules: in vivo effects with relevance to the acute inflammatory response. Proc Natl Acad Sci USA 1981; 78: 3887.
20. Stolpen AH, Guinan EC, Fiers W, Pober JS. Recombinant tumor necrosis factor and immune interferon act singly and in combination to reorganize human vascular endothelial cell monolayers. Am J Pathol 1986; 123:16.
21. Brett J, Gerlach H, Nawroth P, Steinberg S, Godman G, Stern D. Tumor necrosis factor/cachectin increases permeability of endothelial cell monolayers by a mechanism involving regulatory G proteins. J Exp Med 1989; 169:1977.
22. Varani J, Ginsburg I, Schuger L, et al. Endothelial cell killing by neutrophils: synergistic interaction of oxygen products and proteases. Am J Pathol 1989; 135: 435.
23. Young JD-E, Liu C-C, Persechini P-M, Cohn ZA. Perforin-dependent and -independent pathways of cytotoxicity mediated by lymphocytes. Immunol Rev 1988; 103:161.
24. Brigham KL, Meyrick B. Endotoxin and lung injury. Am Rev Respir Dis 1986; 133: 913.
25. Nawroth PP, Handley DA, Esmon CT, Stern DM. Interleukin 1 induces endothelial procoagulant while suppressing cell surface anticoagulant activity. Proc Natl Acad Sci USA 1986; 83: 3460.
26. Varani J, Bendelow MJ, Sealey DE, et al. Tumor necrosis factor enhances susceptibility of vascular endothelial cells to neutrophil-mediated killing. Lab Invest 1988; 59: 292.
27. Hattori R, Hamilton KK, Fugate RD, McEver RD, Sims PJ. Stimulated secretion of endothelial von Willebrand factor is accompanied by rapid redistribution to the cell surface of the intracellular granule membrane protein GMP-140. J Biol Chem 1989; 264: 7768.
28. Geng JG, Bevilacqua MP, Moore KL, et al. Rapid neutrophil adhesion to activated endothelium mediated by GMP-140. Nature 1990; 343: 757.
29. Stoolman LM, Mini review: adhesion molecules controlling lymphocyte migration. Cell 1989; 56: 907.
30. Geoffroy JS, Rosen SD. Demonstration that a lectin-like receptor (gp90MEL) directly mediated adhesion of lymphocytes to high endothelial venules of lymph nodes. J Cell Biol 1989; 109: 2463.
31. Jutila MA, Rott L, Berg EL, Butcher EC. Function and regulation of the neutrophil MEL-14 antigen in vivo: comparison with LFA- 1 and Mac-1. J Immunol 1989; 143: 3318.
32. Zimmerman GA, McIntyre TM, Mehra M, Prescott SM. Endothelial cell-associated platelet-activating factor: a novel mechanism for signalling intracellular adhesion. J Cell Biol 1990; 110: 529.
33. Tonnesen MG, Anderson DC, Springer TA, Knedler A, Avdo N, Henson PM. Adherence of neutrophils to cultured human micro- vascular endothelial cells: stimulation by chemotactic peptides and lipid mediators and dependence upon the Mac-1, LFA-1, pl50, 95 glycoprotein family. J Clin Invest 1989; 83: 637.
34. Dustin ML, Springer TA. T cell receptor cross-linking transiently stimulates adhesiveness through LFA-1. Nature 1989; 341: 619.
35. Dustin ML, Staunton DE, Springer TA. Supergene families meet in the immune system. Immunol Today 1988; 9: 213.
36. Staunton DE, Dustin ML, Springer TA. Functional cloning of ICAM-2, a cell adhesion ligand for LFA-1 homologous to ICAM- 1. Nature 1989; 339: 61.
37. Bjork J, Lindbom L, Gerdin B, Smedegard G, Arfors KE, Benven- iste J. Paf-acether (platelet-activating factor) increases micro- vascular permeability and affects endothelium-granulocyte interaction in microvascular beds. Acta Physiol Scand 1983; 119: 305.
38. Camussi G, Tetta C, Bussoline F, Baglioni C. Synthesis and release of platelet-activating factor is inhibited by plasma ai-protease inhibitor or ai-antichymotrypsin and is stimulated by protein- ases. J Exp Med 1988; 168: 1293.
39. Sun X, Hsueh W, Torre-Amione G. Effects of in vivo priming on endotoxin-induced hypotension and tissue injury: the role of PAF and tumor encrosis factor. Am J Pathol 1990; 136:949.
40. Vevilacqua MP, Pober JS, Mendrick DL, Cotran RS, Gimbrone MA Jr. Identification of an inducible endothelial-leukocyte adhesion molecule. Proc Natl Acad Sci USA 1987; 84: 9238.
41. Cotran RS, Gimbrone MA Jr, Bevilacqua MP, Mendrick DL, Pober JS. Induction and detection of a human endothelial activation antigen in vivo. J Exp Med 1986; 164: 661.
42. Messadi DV, Pober JS, Fiers W, Gimbrone MA Jr, Murphy GE. Induction of an activation antigen on post-capillary venular endothelium in human skin organ culture. J Immunol 1987; 139: 1557.
43. Bevilacqua MP, Stengelin S, Gimbrone MA Jr, Seed B. Endothelial leukocyte adhesion molecule 1: an inducible receptor for neutrophils related to complement regulatory proteins and lectins. Science 1989; 243:1160.
44. Streiter RM, Kunkel SL, Showell HJ, et al. Endothelial gene expression of a neutrophil chemotactic factor by TNF-a, LPS and IL-1. Science 1989; 243:1467.
45. Matsushima K, Oppenheim JJ. Review article: interleukin 8 and MCAF: Novel inflammatory cytokines inducible by IL-1 and TNF. Cytokine 1989; 1: 2.
46. Kishimoto TK, Jutila MA, Butcher EC. Identification of a human peripheral lymph node homing receptor: a rapidly down-regulated adhesion molecule. Proc Natl Acad Sci USA 1990; 87:2244.
47. Detmers PA, Los K, Olsen-Egbert E, Walz A, Baggiolini M, Cohn ZA. Neutrophil-activating protein 1/interleukin 8 stimulates the binding activity of the leukocyte adhesion receptor CD1 lb/CD 18 on human neutrophils. J Exp Med 1990; 171:1155.
48. Gimbrone MA Jr, Obin MS, Brock AF, et al. Endothelial interleukin-8: a novel inhibitor of leukocyte-endothelial interactions. Science 1989; 246:1601.
49. Smith CW, Rothlein R, Hughes BJ, et al. Recognition of an endothelial determinant for CD 18-dependent human neutrophil adherence and transendothelial migration. J Clin Invest 1988; 82:1746.
50. Pober JS, Gimbrone MA Jr, Lapierre LA, et al. Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor and immune interferon. J Immunol 1986; 137:1893.
51. Munro JM, Pober JS, Cotran RS. Tumor necrosis factor and interferon-7 induce distinct patterns of endothelial activation and leukocyte accumulation in skin of Papio anubis. Am J Pathol 1989; 135:121.
52. Rice GE, Bevilacqua MP. An inducible endothelial cell surface glycoprotein mediates melanoma adhesion. Science 1989; 246: 1303.
53. Osborn L, Hession R, Tizard R, et al. Direct expression cloning of vascular cell adhesion molecule 1, a cytokine-induced endothelial protein that binds lymphocytes. Cell 1989; 59:1203.
54. Elices MJ, Osborn L, Takada Y, et al. VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site. Cell 1990; 60: 577.
55. Schwartz BR, Wayner EA, Carlos TM, Ochs HD, Harlan JM. Identification of surface proteins mediating adherence of CD 11/ CD 18-deficient lymphoblastoid cells to cultured human endothelium. J Clin Invest 1990; 85: 2019.
56. Rice GE, Munro JM, Bevilacqua MP. Inducible cell adhesion molecule 110 (INCAM-110) is an endothelial receptor for lymphocytes: a CD ll/CD 18-independent adhesion mechanism. J Exp Med 1990; 171: 1369.
57. Holzmann B, McIntyre BW, Weissman IL. Identification of a murine Peyer’s patch-specific lymphocyte homing receptor as an integrin molecule with an a chain homologous to human VLA- 4a. Cell 1989; 56: 37.
58. Mackay CR, Marston WL, Dudler L. Naive and memory T cells show distinct pathways of lymphocyte recirculation. J Exp Med 1990; 171: 801.
59. Damle NK, Doyle LV, Ability of human T lymphocytes to adhere to vascular endothelial cells and to augment endothelial permeability to macromolecules is linked to their state of post-thymic maturation. J Immunol 1990; 144:1233.
60. Sanders ME, Makgoba MW, Shaw S. Human naive and memory T cells: reinterpretation of helper-inducer and suppressor-indu- cer subsets. Immunol Today 1988; 9:195.
61. Jalkanen S, Bargatze RF, de los Toyos J, Butcher EC. Lymphocyte recognition of high endothelium: antibodies to distinct epitopes of a 85-95 kD glycoprotein antigen differentially inhibit lymphocyte binding to lymph node, mucosal or synovial endothelial cells. J Cell Biol 1987; 105:983.
62. Van Epps DE, Potter J, Vachula M, Smith CW, Anderson DC. Suppression of human lymphocyte chemotaxis and transendo- thelial migration by anti-LFA-1 antibody. J Immunol 1989; 143: 3207.
63. Anderson DC, Schmalsteig FC, Finegold MJ, et al. The severe and moderate phenotypes of heritable Mac-1, LFA-1 deficiency: their quantitative definition and relation to leukocyte dysfunction and clinical features. J Infect Dis 1985; 152: 668.
64. Streiter RM, Wiggins R, Phan SH, et al. Monocyte chemotactic protein gene expression by cytokine-treated human fibroblasts and endothelial cells. Biochem Biophys Res Commun 1989; 162: 694.
65. Sica A, Wang JM, Colotta F, et al. Monocyte chemotactic and activating factor gene expression induced in endothelial cells by IL-1 and tumor necrosis factor. J Immunol 1989; 144: 3034.
66. Rollins BJ, Yoshimura T, Leonard EJ, Pober JS. Cytokine-activated human endothelial cells synthesize and secrete a monocyte chemoattractant, MCP-l/JE. Am J Pathol 1990; 136: 1229.
67. Doukas J, Pober JS. IFN-7 enhances endothelial activation induced by TNF but not IL-1 [Abstract]. FASEB J 1990; 4: A1713 (abstract 111).
68. Montesano R, Mossaz A, Ryser JE, Orci L, Vassalli P. Leukocyte interleukins induce cultured endothelial cells to produce a highly organized glycosaminoglycan-rich pericellular matrix. J Cell Biol 1984; 99:1706.
69. Freemont AJ. Functional and biosynthetic changes in endothelial cells of vessels in chronically inflamed tissues: evidence for endothelial control of lymphocytes* entry into diseased tissues. J Pathol 1988; 155: 225.